+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 16Years - 65Years
All Genders
ID04366999

Study of Bariatric Surgery Effects on Fatty Liver Disease and NASH with Fibrosis in Obese Patients Comparing Sleeve Gastrectomy, Roux-en-Y, and One Anastomosis Gastric Bypass

Led by Beijing Friendship Hospital · Updated on 2024-05-14

320

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying obese patients who need bariatric surgery to assess how effective this surgery is for treating nonalcoholic fatty liver disease NAFLD and nonalcoholic steatohepatitis NASH with fibrosis. The study compares three types of bariatric surgery sleeve gastrectomy SG, Roux-en-Y gastric bypass RYGB, and one anastomosis gastric bypass OAGB. The goal is to understand the independent effects of these surgeries on improving liver disease and fibrosis. This is a prospective, multicenter cohort study that began in 2020 and includes a secondary cohort starting in 2024 based on the original group.

CONDITIONS

Brief Title

Effectiveness of Bariatric Surgery for NAFLD/NASH

Research Team

Z

Zhongtao Zhang, M.D.;Ph.D.

M

Mengyi Li, M.D.;Ph.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here